Jianhui Wu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 9
- Toxicology top 5%
- Immunology and Allergy top 10%
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation 11
- Synthesis and biological activity 7
- Molecular Biology top 10%
- Synthesis and bioactivity of alkaloids 17
- Cancer therapeutics and mechanisms 9
- RNA modifications and cancer 8
-
- Antiplatelet Therapy and Cardiovascular Diseases 9
-
- Nanoparticle-Based Drug Delivery 6
- Journals
- European Journal of Medicinal Chemistry (8 papers)International Journal of Nanomedicine (8 papers)MedChemComm (7 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Jianhui Wu
96 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 298
- Toxicology 53
- Immunology and Allergy 68
- Organic Chemistry 314
- Molecular Biology 724
Countries citing papers authored by Jianhui Wu
This map shows the geographic impact of Jianhui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianhui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianhui Wu more than expected).
Fields of papers citing papers by Jianhui Wu
This network shows the impact of papers produced by Jianhui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianhui Wu. The network helps show where Jianhui Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianhui Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 1 | |
| 7 | Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance | 2020 | 1 |
| 8 | 2020 | 4 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 9 | |
| 11 | 2018 | 2 | |
| 12 | 2018 | 42 | |
| 13 | 2016 | 13 | |
| 14 | 2012 | 141 | |
| 15 | 2012 | 8 | |
| 16 | 2012 | 7 | |
| 17 | 2011 | 3 | |
| 18 | 2010 | 12 | |
| 19 | 2009 | 87 | |
| 20 | 2007 | 23 |
About Jianhui Wu
Jianhui Wu is a scholar working on Cancer Research, Immunology and Allergy and Toxicology, having authored 102 papers that have together received 1.3k indexed citations. Recurring topics across this work include Synthesis and bioactivity of alkaloids (17 papers), Synthesis and Biological Evaluation (11 papers), Cancer therapeutics and mechanisms (9 papers), Cancer-related molecular mechanisms research (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), RNA modifications and cancer (8 papers), Synthesis and biological activity (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). The work is most often cited by research in Cancer Research (298 citations), Toxicology (53 citations) and Immunology and Allergy (68 citations). Jianhui Wu has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Shiqi Peng, Yuji Wang, Ming Zhao, Yaonan Wang, Jianming Tang, Ming Zhao, Meiqing Zheng, Keduo Qian, Jiawang Liu and Kuo‐Hsiung Lee. Their work appears in journals such as European Journal of Medicinal Chemistry, International Journal of Nanomedicine, MedChemComm, Drug Design Development and Therapy and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.